My ePortfolio Register   

AACR 2014 /
New drug demonstrates early promise in metastatic breast cancer

5th - 9th Apr 2014

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 01.05.14
Views: 1738
Rating:

Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio, USA

At a press conference during the AACR conference, Dr Patnaik discussed the use of a new drug called LY2835219 in the treatment of metastatic breast cancer. 

Read the article for more.

Previous conferences: highlights



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence